Showing 1391-1400 of 1676 results for "".
- New Study on AI-Driven Solutions for Diabetic Eye Disease Testing in Underserved Populations Publishedhttps://modernod.com/news/new-study-on-ai-driven-solutions-for-diabetic-eye-disease-testing-in-underserved-populations-published/2482441/Michael D. Abramoff, MD, PhD, founder and executive chairman of Digital Diagnostics, and the creator of the LumineticsCore AI system for diagnosing diabetic retinopathy, has co-authored a study exploring the potential of autono
- University of Toronto Researchers Build Online Glaucoma Simulatorhttps://modernod.com/news/university-of-toronto-researchers-build-online-glaucoma-simulator/2481843/Researchers at the University of Toronto have built an online simulator that is designed to give an improved visual representation of the deterioration caused by glaucoma. The simulator, built by Prof. Willy Wong and PhD candidat
- Researchers Identify Potential Cause of Keratoconushttps://modernod.com/news/researchers-identify-potential-cause-of-keratoconus/2481402/Researchers at the University of North Texas Health Science Center are the first to characterize extracellular vesicles (EVs) in the tears of patients with keratoconus, according to an National Eye Institute news release. Dimitrios Karamichos, PhD, executive director of the North
- Illinois Tech Researcher Awarded $2.5 Million Grant to Prevent Vision Loss in Diabetes Patientshttps://modernod.com/news/illinois-tech-researcher-awarded-2-5-million-grant-to-prevent-vision-loss-in-diabetes-patients/2479432/Illinois Institute of Technology Professor of Biomedical Engineering Jennifer Kang-Mieler, PhD. has received a second research project grant (R01) from the National Institutes of Health to study diabetic retinopathy.
- Kodiak Sciences Announces Presentation of Durability Data from Clinical Development Program of KSI-301 in Wet AMD, DME, and RVO at AAOhttps://modernod.com/news/kodiak-sciences-announces-presentation-of-durability-data-from-clinical-development-program-of-ksi-301-in-wet-amd-dme-and-rvo-at-aao/2476945/Kodiak Sciences announced that Charles C. Wykoff, MD, PhD, will present first-time results at the annual mneeting of the American Academy of Ophthalmology (AAO) to be held in San Francisco. The Retina Subspecialty Day (
- EyePoint Pharmaceuticals Names New Members of Executive Leadership Teamhttps://modernod.com/news/eyepoint-pharmaceuticals-names-new-members-of-executive-leadership-team/2476642/EyePoint Pharmaceuticals announced the appointment of Scott Jones as Chief Commercial Officer and Said Saim, PhD, as Chief Technology Officer. Mr. Jones will be responsible for the commercialization of Dexycu (dexamethasone intraocular suspension) 9% for the treatment of postoperative inflammatio
- Oculis Elects Anthony Rosenberg and David A. Weber to Its Board of Directorshttps://modernod.com/news/oculis-elects-anthony-rosenberg-and-david-a-weber-to-its-board-of-directors/2479867/Oculis announced the appointments of Anthony Rosenberg as Non-Executive Chairman and David A. Weber, PhD, as Non-Executive Director. Together, they bring more than 60 years’ experience from the global pharmaceutical and eye care industries to the compa
- Kowa Initiates Phase 3 Safety Trial for Glaucoma Drug Candidate NCX 470 in Japanhttps://modernod.com/news/kowa-initiates-phase-3-safety-trial-for-glaucoma-drug-candidate-ncx-470-in-japan/2482918/Nicox announced that its exclusive Japanese partner, Kowa, has officially initiated a phase 3 safety clinical trial for NCX 470 (also referred to as K-911) in Japan. NCX 470 is Nicox’s lead clinical candidate, currently undergoing phase 3 clinical evaluations
- Oculus Launches Myopia Software Package on the Pentacam AXL Wavehttps://modernod.com/news/oculus-launches-myopia-software-package-on-the-pentacam-axl-wave/2482670/Oculus is launching the Myopia Software Package on the Pentacam AXL Wave. The new software is designed to offer optometrists improved accuracy, ease, and safety in their myopia management, comprehensive screening, and ortho-k fitting with one device. The Pentacam AXL
- FDA Clears New World Medical's VIA360 Surgical Systemhttps://modernod.com/news/fda-clears-new-world-medicals-via360-surgical-system/2482667/New World Medical has received 510(k) clearance from the FDA for its VIA360 Surgical System for the delivery of controlled amounts of viscoelastic fluid during ophthalmic surgeries. The VIA360, which is also indicated to cut trabecular meshwork tissue during trabecul